| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.894 | 0.004 | 0.894 | Antiadrenergic | 0.234 0.019 CID_129627137 | ||
| 0.893 | 0.004 | 0.893 | Adrenaline antagonist | 0.232 0.019 CID_129627137 | ||
| 0.84 | 0.003 | 0.84 | Vasodilator, peripheral | 0.755 0.004 CID_129627137 | ||
| 0.699 | 0.007 | 0.699 | 5 Hydroxytryptamine release stimulant | 0.454 0.035 CID_129627137 | ||
| 0.661 | 0.005 | 0.661 | Cardiotonic | 0.324 0.047 CID_129627137 | ||
| 0.58 | 0.002 | 0.58 | Beta adrenoreceptor antagonist | 0.087 0.023 CID_129627137 | ||
| 0.586 | 0.008 | 0.683 | Vasodilator, coronary | 0.683 0.005 CID_129627137 | CID_129627137 | |
| 0.548 | 0.018 | 0.548 | Spasmolytic | 0.453 0.03 CID_129627137 | ||
| 0.532 | 0.005 | 0.532 | Alpha adrenoreceptor antagonist | |||
| 0.526 | 0.01 | 0.526 | Vasodilator | 0.508 0.011 CID_129627137 | ||
| 0.509 | 0.002 | 0.509 | Beta 1 adrenoreceptor antagonist | 0.057 0.038 CID_129627137 | ||
| 0.486 | 0.002 | 0.486 | Beta 3 adrenoreceptor antagonist | 0.071 0.032 CID_129627137 | ||
| 0.499 | 0.033 | 0.499 | Aldehyde oxidase inhibitor | |||
| 0.468 | 0.01 | 0.468 | P-glycoprotein inhibitor | 0.246 0.042 CID_129627137 | ||
| 0.456 | 0.005 | 0.456 | Alpha 1 adrenoreceptor antagonist | |||
| 0.449 | 0.002 | 0.449 | Beta 2 adrenoreceptor antagonist | 0.056 0.028 CID_129627137 | ||
| 0.502 | 0.059 | 0.502 | Caspase 9 stimulant | 0.484 0.066 CID_129627137 | ||
| 0.456 | 0.018 | 0.456 | DNA damaging | 0.449 0.019 CID_129627137 | ||
| 0.434 | 0.014 | 0.434 | Calcium channel activator | 0.25 0.147 CID_129627137 | ||
| 0.403 | 0.003 | 0.403 | Adrenaline agonist | |||
| 0.408 | 0.015 | 0.408 | Cyclic AMP phosphodiesterase inhibitor | 0.37 0.021 CID_129627137 | ||
| 0.397 | 0.018 | 0.397 | Sodium/bile acid cotransporter inhibitor | 0.323 0.06 CID_129627137 | ||
| 0.433 | 0.06 | 0.433 | Calcium channel L-type activator | 0.297 0.16 CID_129627137 | ||
| 0.367 | 0.006 | 0.367 | Alpha 1a adrenoreceptor antagonist | |||
| 0.369 | 0.009 | 0.369 | Interleukin 6 antagonist | 0.249 0.023 CID_129627137 | ||
| 0.335 | 0.005 | 0.335 | Alpha 1d adrenoreceptor antagonist | |||
| 0.338 | 0.01 | 0.338 | Insulin sensitizer | 0.22 0.055 CID_129627137 | ||
| 0.33 | 0.006 | 0.33 | Alpha 1b adrenoreceptor antagonist | |||
| 0.339 | 0.016 | 0.339 | DNA methyltransferase I inhibitor | 0.321 0.02 CID_129627137 | ||
| 0.397 | 0.077 | 0.463 | Histamine release inhibitor | 0.463 0.044 CID_129627137 | CID_129627137 | |
| 0.325 | 0.008 | 0.325 | 5 Hydroxytryptamine 1A antagonist | |||
| 0.322 | 0.022 | 0.362 | DNA methylase inhibitor | 0.362 0.015 CID_129627137 | CID_129627137 | |
| 0.33 | 0.042 | 0.33 | Interleukin antagonist | |||
| 0.29 | 0.005 | 0.29 | Calcium antagonist | |||
| 0.377 | 0.093 | 0.377 | 5 Hydroxytryptamine release inhibitor | 0.324 0.14 CID_129627137 | ||
| 0.288 | 0.008 | 0.288 | Topoisomerase II alpha inhibitor | 0.278 0.009 CID_129627137 | ||
| 0.289 | 0.014 | 0.289 | Insulin secretagoues | 0.261 0.018 CID_129627137 | ||
| 0.376 | 0.105 | 0.607 | Cyclophilin D inhibitor | 0.607 0.026 CID_129627137 | CID_129627137 | |
| 0.285 | 0.014 | 0.285 | Anesthetic local | |||
| 0.308 | 0.048 | 0.308 | Superoxide dismutase inhibitor | |||
| 0.267 | 0.012 | 0.267 | 5 Hydroxytryptamine 1 antagonist | |||
| 0.305 | 0.051 | 0.305 | Transcription factor STAT3 inhibitor | |||
| 0.249 | 0.015 | 0.249 | Alpha 2b adrenoreceptor antagonist | |||
| 0.242 | 0.02 | 0.242 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.273 | 0.051 | 0.273 | Psychostimulant | 0.172 0.098 CID_129627137 | ||
| 0.278 | 0.061 | 0.528 | Hypoglycemic | 0.528 0.013 CID_129627137 | CID_129627137 | |
| 0.294 | 0.082 | 0.315 | Caspase 3 stimulant | 0.315 0.072 CID_129627137 | CID_129627137 | |
| 0.302 | 0.093 | 0.64 | Transcription factor NF kappa B inhibitor | 0.64 0.027 CID_129627137 | CID_129627137 | |
| 0.231 | 0.027 | 0.306 | Topoisomerase II inhibitor | 0.306 0.017 CID_129627137 | CID_129627137 | |
| 0.295 | 0.094 | 0.524 | Cholesterol antagonist | 0.524 0.029 CID_129627137 | CID_129627137 | |
| 0.28 | 0.079 | 0.28 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | |||
| 0.214 | 0.015 | 0.214 | Alpha 2 adrenoreceptor antagonist | |||
| 0.258 | 0.061 | 0.258 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.212 | 0.023 | 0.38 | Alkylator | 0.38 0.008 CID_129627137 | CID_129627137 | |
| 0.204 | 0.022 | 0.204 | Toll-Like receptor 2 antagonist | 0.105 0.097 CID_129627137 | ||
| 0.2 | 0.019 | 0.2 | Nav1.6 sodium channel blocker | |||
| 0.2 | 0.024 | 0.2 | Nav1.3 sodium channel blocker | |||
| 0.177 | 0.003 | 0.177 | Beta adrenoreceptor agonist | |||
| 0.198 | 0.027 | 0.282 | Topoisomerase I inhibitor | 0.282 0.013 CID_129627137 | CID_129627137 | |
| 0.195 | 0.027 | 0.204 | DNA intercalator | 0.204 0.024 CID_129627137 | CID_129627137 | |
| 0.321 | 0.158 | 0.554 | Apoptosis agonist | 0.554 0.059 CID_129627137 | CID_129627137 | |
| 0.165 | 0.002 | 0.165 | Beta 3 adrenoreceptor agonist | |||
| 0.229 | 0.067 | 0.35 | Peptidyltransferase inhibitor | 0.35 0.012 CID_129627137 | CID_129627137 | |
| 0.224 | 0.067 | 0.224 | ErbB-1 antagonist | |||
| 0.179 | 0.027 | 0.179 | MAP3K9 inhibitor | |||
| 0.187 | 0.035 | 0.187 | Calcium channel blocker | |||
| 0.216 | 0.066 | 0.216 | Nitric-oxide synthase stimulant | 0.179 0.13 CID_129627137 | ||
| 0.185 | 0.038 | 0.185 | 5 Hydroxytryptamine antagonist | |||
| 0.175 | 0.03 | 0.175 | Adenylate cyclase stimulant | |||
| 0.157 | 0.021 | 0.157 | Breast cancer-resistant protein inhibitor | |||
| 0.272 | 0.138 | 0.272 | Antiobesity | |||
| 0.156 | 0.024 | 0.156 | Gastric antisecretory | |||
| 0.136 | 0.005 | 0.136 | 5 Hydroxytryptamine 1B agonist | |||
| 0.158 | 0.029 | 0.158 | Alpha 2c adrenoreceptor antagonist | |||
| 0.179 | 0.05 | 0.179 | Cyclin-dependent kinase 3 inhibitor | |||
| 0.317 | 0.19 | 0.317 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.174 | 0.047 | 0.174 | GABA C receptor rho-2 antagonist | |||
| 0.205 | 0.079 | 0.205 | MAP kinase kinase 2 inhibitor | |||
| 0.228 | 0.104 | 0.228 | Transcription factor STAT inhibitor | |||
| 0.163 | 0.041 | 0.163 | MAP kinase kinase 4 inhibitor | |||
| 0.198 | 0.079 | 0.243 | Amyloid beta aggregation inhibitor | 0.243 0.06 CID_129627137 | CID_129627137 | |
| 0.14 | 0.022 | 0.14 | ALK inhibitor | |||
| 0.167 | 0.051 | 0.167 | Tubulin antagonist | |||
| 0.151 | 0.037 | 0.151 | Vanilloid 1 agonist | 0.14 0.049 CID_129627137 | ||
| 0.117 | 0.003 | 0.117 | Calcium-sensing receptor antagonist | |||
| 0.126 | 0.014 | 0.126 | Calcium channel L-type blocker | |||
| 0.119 | 0.012 | 0.119 | Phosphodiesterase VI inhibitor | 0.104 0.018 CID_129627137 | ||
| 0.142 | 0.036 | 0.142 | Protein kinase C gamma inhibitor | |||
| 0.119 | 0.015 | 0.119 | Phosphodiesterase III inhibitor | |||
| 0.17 | 0.069 | 0.17 | Peroxidase inhibitor | |||
| 0.133 | 0.032 | 0.184 | Toll-Like receptor 4 antagonist | 0.184 0.009 CID_129627137 | CID_129627137 | |
| 0.153 | 0.054 | 0.153 | Toll-Like receptor antagonist | |||
| 0.104 | 0.006 | 0.104 | Sphingosine 1-phosphate receptor 3 agonist | |||
| 0.12 | 0.025 | 0.139 | Phosphodiesterase 6D inhibitor | 0.139 0.013 CID_129627137 | CID_129627137 | |
| 0.126 | 0.03 | 0.126 | MAP kinase kinase 1 inhibitor | |||
| 0.195 | 0.103 | 0.385 | Antiamyloidogenic | 0.385 0.031 CID_129627137 | CID_129627137 | |
| 0.097 | 0.006 | 0.097 | Calcium channel P-type blocker | |||
| 0.119 | 0.029 | 0.119 | Alpha 2a adrenoreceptor antagonist | |||
| 0.183 | 0.094 | 0.183 | Antimitotic | |||
| 0.117 | 0.032 | 0.117 | Toll-Like receptor 3 antagonist | |||
| 0.089 | 0.005 | 0.089 | Beta 2 adrenoreceptor agonist | |||
| 0.085 | 0.003 | 0.085 | Beta 1 adrenoreceptor agonist | |||
| 0.242 | 0.161 | 0.242 | GABA C receptor rho-3 antagonist | |||
| 0.149 | 0.069 | 0.233 | Lipid peroxidase inhibitor | 0.233 0.03 CID_129627137 | CID_129627137 | |
| 0.119 | 0.041 | 0.119 | GABA C receptor rho-1 antagonist | |||
| 0.161 | 0.084 | 0.249 | ATPase inhibitor | 0.249 0.014 CID_129627137 | CID_129627137 | |
| 0.119 | 0.045 | 0.119 | Bronchodilator | |||
| 0.121 | 0.048 | 0.35 | AMP-activated protein kinase stimulant | 0.35 0.004 CID_129627137 | CID_129627137 | |
| 0.111 | 0.039 | 0.111 | 5 Hydroxytryptamine 2C antagonist | |||
| 0.08 | 0.009 | 0.08 | Sphingosine 1-phosphate receptor agonist | |||
| 0.182 | 0.113 | 0.462 | Free radical scavenger | 0.462 0.02 CID_129627137 | CID_129627137 | |
| 0.221 | 0.153 | 0.583 | Antithrombotic | 0.583 0.018 CID_129627137 | CID_129627137 | |
| 0.191 | 0.126 | 0.48 | Immunostimulant | 0.48 0.032 CID_129627137 | CID_129627137 | |
| 0.187 | 0.125 | 0.477 | Antioxidant | 0.477 0.023 CID_129627137 | CID_129627137 | |
| 0.074 | 0.013 | 0.074 | Ryanodine receptor antagonist | |||
| 0.09 | 0.028 | 0.09 | Fibroblast growth factor 2 antagonist | |||
| 0.104 | 0.044 | 0.104 | NMDA receptor antagonist | |||
| 0.117 | 0.057 | 0.117 | Mucolytic | 0.102 0.075 CID_129627137 | ||
| 0.084 | 0.024 | 0.084 | 5 Hydroxytryptamine 2A agonist | |||
| 0.068 | 0.009 | 0.068 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.108 | 0.051 | 0.108 | Sphingomyelinase inhibitor | 0.091 0.071 CID_129627137 | ||
| 0.077 | 0.021 | 0.077 | Cyclin D1 inhibitor | |||
| 0.091 | 0.037 | 0.091 | Keratolytic | |||
| 0.092 | 0.038 | 0.092 | Telomerase inhibitor | |||
| 0.097 | 0.044 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.104 0.034 CID_129627137 | CID_129627137 | |
| 0.093 | 0.044 | 0.093 | Carbonic anhydrase VI inhibitor | |||
| 0.243 | 0.199 | 0.243 | MAP kinase kinase 6 inhibitor | |||
| 0.105 | 0.061 | 0.105 | Nav1.1 sodium channel blocker | |||
| 0.094 | 0.053 | 0.1 | Glutamate release inhibitor | 0.1 0.043 CID_129627137 | CID_129627137 | |
| 0.067 | 0.03 | 0.067 | Alpha 1 adrenoreceptor agonist | |||
| 0.089 | 0.053 | 0.089 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.102 | 0.066 | 0.208 | Expectorant | 0.208 0.019 CID_129627137 | CID_129627137 | |
| 0.108 | 0.074 | 0.146 | Photosensitizer | 0.146 0.033 CID_129627137 | CID_129627137 | |
| 0.073 | 0.039 | 0.073 | 5 Hydroxytryptamine 1B antagonist | |||
| 0.147 | 0.114 | 0.147 | Death-associated protein kinase 2 inhibitor | |||
| 0.084 | 0.051 | 0.084 | Phosphodiesterase XI inhibitor | |||
| 0.084 | 0.051 | 0.084 | Phosphodiesterase 11A inhibitor | |||
| 0.118 | 0.086 | 0.118 | Nav1.2 sodium channel blocker | |||
| 0.096 | 0.066 | 0.096 | Carbonic anhydrase III inhibitor | |||
| 0.117 | 0.086 | 0.117 | Antibacterial (Helicobacter pylori) | |||
| 0.061 | 0.032 | 0.061 | 5 Hydroxytryptamine 1 agonist | |||
| 0.064 | 0.036 | 0.064 | Bombesin 1 receptor agonist | |||
| 0.077 | 0.05 | 0.077 | GABA B receptor agonist | |||
| 0.211 | 0.185 | 0.424 | Immunosuppressant | 0.424 0.055 CID_129627137 | CID_129627137 | |
| 0.11 | 0.084 | 0.11 | MAP kinase kinase inhibitor | |||
| 0.151 | 0.127 | 0.151 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.077 | 0.054 | 0.077 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.11 | 0.088 | 0.335 | Amylase inhibitor | 0.335 0.014 CID_129627137 | CID_129627137 | |
| 0.083 | 0.062 | 0.083 | Vanilloid agonist | |||
| 0.089 | 0.068 | 0.089 | Protein kinase C zeta inhibitor | |||
| 0.096 | 0.075 | 0.096 | 5 Hydroxytryptamine 2 antagonist | |||
| 0.06 | 0.042 | 0.06 | Dopamine D4 antagonist | |||
| 0.062 | 0.044 | 0.07 | Nitric oxide donor | 0.07 0.032 CID_129627137 | CID_129627137 | |
| 0.1 | 0.083 | 0.1 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.054 | 0.038 | 0.054 | Myc inhibitor | |||
| 0.104 | 0.09 | 0.104 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.107 | 0.093 | 0.208 | Cyclooxygenase 3 inhibitor | 0.208 0.016 CID_129627137 | CID_129627137 | |
| 0.079 | 0.066 | 0.079 | Antineoplastic alkaloid | |||
| 0.053 | 0.041 | 0.053 | Epithelial sodium channel blocker | |||
| 0.043 | 0.034 | 0.043 | 5 Hydroxytryptamine 1A agonist | |||
| 0.118 | 0.111 | 0.118 | Acetylcholine M1 receptor antagonist | |||
| 0.023 | 0.017 | 0.023 | Dopamine autoreceptor agonist | |||
| 0.026 | 0.02 | 0.04 | Toll-Like receptor 4 agonist | 0.04 0.005 CID_129627137 | CID_129627137 | |
| 0.045 | 0.043 | 0.045 | Bombesin 2 receptor antagonist | |||
| 0.092 | 0.091 | 0.092 | GABA C receptor antagonist | |||
| 0.192 | 0.191 | 0.429 | Apoptosis antagonist | 0.429 0.031 CID_129627137 | CID_129627137 | |
| 0.046 | 0.051 | 0.053 | Protein kinase C eta inhibitor | 0.053 0.04 CID_129627137 | CID_129627137 | |
| 0.016 | 0.023 | 0.03 | Antibiotic Anthracycline-like | 0.03 0.004 CID_129627137 | CID_129627137 | |
| 0.011 | 0.022 | 0.015 | Ileal bile acid transport inhibitor | 0.015 0.014 CID_129627137 | CID_129627137 | |
| 0.12 | 0.135 | 0.145 | Melanin inhibitor | 0.145 0.088 CID_129627137 | CID_129627137 | |
| 0.087 | 0.117 | 0.114 | Microtubule formation inhibitor | 0.114 0.069 CID_129627137 | CID_129627137 | |
| 0.1 | 0.131 | 0.173 | DNA repair enzyme inhibitor | 0.173 0.016 CID_129627137 | CID_129627137 | |
| 0.026 | 0.059 | 0.062 | Antibiotic Aminoglycoside-like | 0.062 0.008 CID_129627137 | CID_129627137 | |
| 0.026 | 0.062 | 0.032 | Protein kinase C beta I inhibitor | 0.032 0.028 CID_129627137 | CID_129627137 | |
| 0.127 | 0.164 | 0.205 | Hypolipemic | 0.205 0.09 CID_129627137 | CID_129627137 | |
| 0.112 | 0.156 | 0.326 | Platelet adhesion inhibitor | 0.326 0.026 CID_129627137 | CID_129627137 | |
| 0.016 | 0.062 | 0.048 | Sodium/glucose cotransporter inhibitor | 0.048 0.005 CID_129627137 | CID_129627137 | |
| 0.036 | 0.086 | 0.049 | Alpha-mannosidase inhibitor | 0.049 0.046 CID_129627137 | CID_129627137 | |
| 0.077 | 0.129 | 0.122 | Multidrug resistance-associated protein 1 inhibitor | 0.122 0.046 CID_129627137 | CID_129627137 | |
| 0.035 | 0.087 | 0.299 | Selectin antagonist | 0.299 0.005 CID_129627137 | CID_129627137 | |
| 0.013 | 0.068 | 0.048 | Sodium/glucose cotransporter 2 inhibitor | 0.048 0.007 CID_129627137 | CID_129627137 | |
| 0.025 | 0.084 | 0.041 | Mannosidase inhibitor | 0.041 0.038 CID_129627137 | CID_129627137 | |
| 0.123 | 0.181 | 0.238 | Platelet antagonist | 0.238 0.078 CID_129627137 | CID_129627137 | |
| 0.079 | 0.14 | 0.108 | Alpha-N-acetylglucosaminidase inhibitor | 0.108 0.09 CID_129627137 | CID_129627137 | |
| 0.063 | 0.126 | 0.115 | NADH dehydrogenase inhibitor | 0.115 0.031 CID_129627137 | CID_129627137 | |
| 0.013 | 0.076 | 0.035 | Protein 30S ribosomal subunit inhibitor | 0.035 0.011 CID_129627137 | CID_129627137 | |
| 0.126 | 0.193 | 0.358 | Tumour necrosis factor alpha release inhibitor | 0.358 0.036 CID_129627137 | CID_129627137 | |
| 0.144 | 0.216 | 0.291 | DNA synthesis inhibitor | 0.291 0.047 CID_129627137 | CID_129627137 | |
| 0.101 | 0.175 | 0.31 | Nitric oxide antagonist | 0.31 0.039 CID_129627137 | CID_129627137 | |
| 0.056 | 0.133 | 0.112 | Mediator release inhibitor | 0.112 0.056 CID_129627137 | CID_129627137 | |
| 0.039 | 0.117 | 0.072 | Na+ K+ transporting ATPase inhibitor | 0.072 0.058 CID_129627137 | CID_129627137 | |
| 0.06 | 0.139 | 0.116 | UDP-glucose 4-epimerase inhibitor | 0.116 0.046 CID_129627137 | CID_129627137 | |
| 0.034 | 0.114 | 0.155 | Antineoplastic antibiotic | 0.155 0.03 CID_129627137 | CID_129627137 | |
| 0.024 | 0.106 | 0.043 | Neuraminidase (Influenza A) inhibitor | 0.043 0.037 CID_129627137 | CID_129627137 | |
| 0.058 | 0.142 | 0.082 | Triose-phosphate isomerase inhibitor | 0.082 0.073 CID_129627137 | CID_129627137 | |
| 0.103 | 0.188 | 0.357 | Hepatoprotectant | 0.357 0.018 CID_129627137 | CID_129627137 | |
| 0.063 | 0.151 | 0.136 | DNA polymerase I inhibitor | 0.136 0.057 CID_129627137 | CID_129627137 | |
| 0.083 | 0.18 | 0.489 | Angiogenesis stimulant | 0.489 0.012 CID_129627137 | CID_129627137 | |
| 0.034 | 0.14 | 0.075 | Neuraminidase (influenza) inhibitor | 0.075 0.03 CID_129627137 | CID_129627137 | |
| 0.062 | 0.169 | 0.161 | Beta glucuronidase inhibitor | 0.161 0.021 CID_129627137 | CID_129627137 | |
| 0.097 | 0.208 | 0.15 | Interferon gamma antagonist | 0.15 0.078 CID_129627137 | CID_129627137 | |
| 0.057 | 0.178 | 0.085 | Xanthine oxidase inhibitor | 0.085 0.081 CID_129627137 | CID_129627137 | |
| 0.028 | 0.151 | 0.087 | Heparanase inhibitor | 0.087 0.005 CID_129627137 | CID_129627137 | |
| 0.063 | 0.193 | 0.211 | Thrombolytic | 0.211 0.047 CID_129627137 | CID_129627137 | |
| 0.02 | 0.154 | 0.06 | Neuraminidase inhibitor | 0.06 0.043 CID_129627137 | CID_129627137 | |
| 0.067 | 0.212 | 0.112 | Interleukin 4 antagonist | 0.112 0.098 CID_129627137 | CID_129627137 | |
| 0.057 | 0.21 | 0.108 | Alkaline phosphatase inhibitor | 0.108 0.103 CID_129627137 | CID_129627137 | |
| 0.122 | 0.285 | 0.259 | Angiogenesis inhibitor | 0.259 0.117 CID_129627137 | CID_129627137 | |
| 0.018 | 0.184 | 0.084 | Protein 50S ribosomal subunit inhibitor | 0.084 0.018 CID_129627137 | CID_129627137 | |
| 0.024 | 0.201 | 0.058 | Glucose-6-phosphate translocase inhibitor | 0.058 0.027 CID_129627137 | CID_129627137 | |
| 0.073 | 0.266 | 0.226 | Interleukin agonist | 0.226 0.098 CID_129627137 | CID_129627137 | |
| 0.024 | 0.232 | 0.12 | Monophenol monooxygenase inhibitor | 0.12 0.061 CID_129627137 | CID_129627137 | |
| 0.047 | 0.26 | 0.105 | Transcription factor NF kappa B stimulant | 0.105 0.034 CID_129627137 | CID_129627137 | |
| 0.129 | 0.362 | 0.388 | Interleukin 2 agonist | 0.388 0.031 CID_129627137 | CID_129627137 | |
| 0.029 | 0.29 | 0.072 | Adenine nucleotide translocase inhibitor | 0.072 0.014 CID_129627137 | CID_129627137 | |
| 0.11 | 0.376 | 0.533 | Antibacterial | 0.533 0.032 CID_129627137 | CID_129627137 | |
| 0.021 | 0.293 | 0.049 | Factor IXa inhibitor | 0.049 0.039 CID_129627137 | CID_129627137 | |
| 0.062 | 0.404 | 0.282 | Alpha-glucosidase inhibitor | 0.282 0.169 CID_129627137 | CID_129627137 | |
| 0.051 | 0.403 | 0.2 | Hemostatic | 0.2 0.033 CID_129627137 | CID_129627137 | |
| 0.033 | 0.443 | 0.114 | Cell adhesion inhibitor | 0.114 0.07 CID_129627137 | CID_129627137 | |
| 0.065 | 0.503 | 0.278 | Immunomodulator | 0.278 0.095 CID_129627137 | CID_129627137 | |
| 0.02 | 0.539 | 0.13 | Anticoagulant | 0.13 0.101 CID_129627137 | CID_129627137 | |
| 0.035 | 0.659 | 0.126 | NOS3 expression enhancer | 0.126 0.104 CID_129627137 | CID_129627137 | |
| 0.027 | 0.782 | 0.44 | Antiinflammatory | 0.44 0.115 CID_129627137 | CID_129627137 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |